<p><strong>Pediatric use</strong>: Safety and effectiveness in paediatric patients have not been established.<br />
<br />
<strong>Geriatric use</strong>: No overall difference in the efficacy or safety of Valsartan was observed in this patient population, but greater sensitivity of some elderly persons cannot be ruled out.<br />
<br />
Hepatic Impairment:</p>

<ul>
	<li><strong>Mild to moderate</strong>: Max: 80 mg once daily.</li>
	<li><strong>Severe</strong>: Contraindicated.</li>
</ul>